The trends are clear: Payers, Employers, and Patients across the nation are concerned about skyrocketing specialty claim costs.  A few jaw-dropping facts quickly illustrate the pattern of rising costs. Specialty drugs are one of the fastest growing segments of the healthcare sector with specialty drug costs projected to represent 55% of all drug spend by 2020. However, most of the focus is on the pharmacy spend and overlooks approximately 50% of specialty drug spend that is occurring under a payer or plan sponsor medical benefit.  How can these costs be managed without being a constant financial drain on your company resources?

Join Zelis Healthcare’s Dr. Steven Wolinsky for an exclusive webinar on mitigating the high cost of medical claims for your organization through technology and clinical expertise.

Featured Speaker

Dr. Steven Wolinksy, MD

Chief Medical Officer
Zelis Healthcare

Steven Wolinsky MD is a board-certified internist, a graduate of the University of Pennsylvania, the Case Western Reserve University School of Medicine and the SUNY Downstate Brookdale Hospital residency programs.  He had an active internal medicine practice from 1984 to 1996, and from 1997 to 2015 he served as a Senior Medical Director for Blue Cross plans in NY and NJ, with responsibility for medical cost control and payment integrity.  Since 2016 he has served as the Chief Medical Officer of Zelis Healthcare, with responsibilities for clinical leadership, new clinical products, client management, payment integrity, claim editing and clinically-derived revenue.  In all of his roles, Dr. Wolinsky has demonstrated his passion to contain medical costs for his clients.


Register now for this webinar